Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.6200
+0.0300 (5.08%)
Last updated: Jan 9, 2026, 8:02 AM CET
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €26.66 million as of January 9, 2026. Its market cap has decreased by -40.60% in one year.
Market Cap
26.66M
Enterprise Value
-27.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.62
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 26.66M, a decrease of -93.32%. That is a compound annual growth rate of -43.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 26.66M | 9.50% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | 399.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |